Mymd Pharmaceuticals Stock Revenue
| MYMDDelisted Stock | USD 1.82 0.02 1.09% |
MyMD Pharmaceuticals fundamentals help investors to digest information that contributes to MyMD Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of MyMD Stock. The fundamental analysis module provides a way to measure MyMD Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to MyMD Pharmaceuticals stock.
MyMD |
MyMD Pharmaceuticals Company Revenue Analysis
MyMD Pharmaceuticals' Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
CompetitionBased on the latest financial disclosure, MyMD Pharmaceuticals reported 0.0 of revenue. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The revenue for all United States stocks is 100.0% higher than that of the company.
MyMD Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses MyMD Pharmaceuticals' direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of MyMD Pharmaceuticals could also be used in its relative valuation, which is a method of valuing MyMD Pharmaceuticals by comparing valuation metrics of similar companies.MyMD Pharmaceuticals is currently under evaluation in revenue category among its peers.
MyMD Fundamentals
| Return On Equity | -1.01 | |||
| Return On Asset | -0.5 | |||
| Current Valuation | 2.99 M | |||
| Shares Outstanding | 2.37 M | |||
| Shares Owned By Insiders | 6.61 % | |||
| Shares Owned By Institutions | 6.62 % | |||
| Number Of Shares Shorted | 263.62 K | |||
| Price To Book | 0.46 X | |||
| EBITDA | (17.12 M) | |||
| Net Income | (4 M) | |||
| Cash And Equivalents | 5.62 M | |||
| Cash Per Share | 0.15 X | |||
| Total Debt | 48.87 K | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 2.41 X | |||
| Book Value Per Share | 4.54 X | |||
| Cash Flow From Operations | (12.98 M) | |||
| Short Ratio | 2.71 X | |||
| Earnings Per Share | (9.27) X | |||
| Beta | 2.69 | |||
| Market Capitalization | 4.31 M | |||
| Total Asset | 17.86 M | |||
| Retained Earnings | (101.98 M) | |||
| Working Capital | 828.25 K | |||
| Net Asset | 17.86 M |
About MyMD Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze MyMD Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MyMD Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MyMD Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Consideration for investing in MyMD Stock
If you are still planning to invest in MyMD Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MyMD Pharmaceuticals' history and understand the potential risks before investing.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |